PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 1990Circulation Research174 citationsOpen Access

Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats.

View Full Paper
DMDebabrata MukherjeeSSS Sen

Structured PICO

Does captopril alter collagen phenotypes and regress myocardial hypertrophy in spontaneously hypertensive rats?

P
Population
Spontaneously hypertensive rats and normotensive rats
I
Intervention
Captopril (angiotensin-converting enzyme inhibitor)
C
Comparator
Normotensive rats receiving captopril (and implied untreated hypertensive rats)
O
Outcome
Total amount of collagen and distribution/ratio of type I and type III collagensurrogate

Captopril therapy reverses myocardial hypertrophy and normalizes the collagen matrix composition in spontaneously hypertensive rats.

Abstract

The myocardium contains collagen matrix that is a major determinant of its architecture, structural integrity, and mechanical properties. This fibrillar matrix consists primarily of type I and type III collagens having epimysial, perimysial, and endomysial components. The present study shows the alteration of collagen phenotypes during the evolution of hypertensive hypertrophy. Therapy with captopril, an angiotensin-converting enzyme inhibitor that regresses cardiac hypertrophy, not only reduces the total amount of collagen but reverses the altered distribution of type I and type III collagen. In normotensive rats, captopril did not significantly reduce collagen content or alter the ratio of type I to type III collagen.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mukherjee et al. (1990) studied this question.

synapsesocial.com/papers/6a1e8f588633267d4d02a7cehttps://doi.org/10.1161/01.res.67.6.1474
Ask AI
Helpful
Bookmark
Share
View Full Paper